Cannara Biotech, Inc. (LOVFF)
1.22
0.00 (0.00%)
USD |
OTCM |
Dec 24, 16:00
Cannara Biotech EPS Diluted (Quarterly): 0.0264 for Aug. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.3157 |
| Lexaria Bioscience Corp. | -0.1378 |
| Xenon Pharmaceuticals, Inc. | -1.147 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.415M |
| Revenue (Quarterly) | 20.65M |
| Total Expenses (Quarterly) | 18.23M |
| Enterprise Value | 135.71M |
| Gross Profit Margin (Quarterly) | 12.11% |
| Profit Margin (Quarterly) | 11.70% |
| Earnings Yield | 8.33% |
| Normalized Earnings Yield | -4.893 |